Remove diabetes
article thumbnail

CGM Use Linked to Improved Diabetic Retinopathy Outcomes in T1D

Drug Topics

The current study highlights the potential benefit of incorporating continuous glucose monitor (CGM) data into eye care assessments for patients with type 1 diabetes (T1D).

220
220
article thumbnail

CGM Education Needed to Promote Equitable Diabetes Care

Drug Topics

Continuous glucose monitors (CGMs) empower patients with diabetes to take a more active role in managing their condition, but without proper training, many of these advantages become limited.

112
112
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Dexcom Submits New CGM For Non-Insulin Type 2 Diabetes for FDA Clearance

Drug Topics

Although continous glucose monitors (CGMs) have often been tailored to patients with type 1 diabetes, data elicited by these technologies add value to the management of type 2 diabetes by offering insights into patients’ unique responses to food, activity, medications, and more.

FDA 212
article thumbnail

Diabetes Can Serve as Traumatic Stressor for Adolescents, Young Adults

Drug Topics

A new study found that over a quarter of participants with type 1 daiebets exhibited clinically relevant levels of posttraumatic stress symptoms related to a diabetes event that they experienced.

201
201
article thumbnail

Heparanase Inhibitors May Reduce Risk of Diabetic Kidney Disease, Diabetic Retinopathy in Patients with Diabetes

Pharmacy Times

This agent can prevent the depletion of heparan sulphate in the endothelial glycocalyx layer of endothelial cells, ultimately protecting against vision loss and renal failure caused by diabetes.

123
123
article thumbnail

Diabetes Mortality Trends Remained Steady in the Americas Over 20-Year Period

Drug Topics

Although diabetes mortality rates were stable in the Americas over the past 2 decades, the actual number of diabetes-related deaths is rising.

187
187
article thumbnail

COVID-19 Pandemic Exacerbated Functional Limitations Among Older Adults With Diabetes

Drug Topics

Overall, older adults with diabetes faced a 53% higher risk of developing at least 1 functional limitation during the pandemic compared to older adults without diabetes.

112
112